Application Nr Approved Date Route Status External Links
ANDA206653 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Duloxetine Delayed-Release Capsules, Usp Are Indicated For The Treatment Of: • Major Depressive Disorder [See Clinical Studies ( 14.1 )] • Generalized Anxiety Disorder [See Clinical Studies ( 14.2 )] • Diabetic Peripheral Neuropathy [See Clinical Studies ( 14.3 )] • Chronic Musculoskeletal Pain [See Clinical Studies ( 14.5 )] Duloxetine Is A Serotonin And Norepinephrine Reuptake Inhibitor (Snri) Indicated For: • Major Depressive Disorder (Mdd) ( 1 ) • Generalized Anxiety Disorder (Gad) ( 1 ) • Diabetic Peripheral Neuropathic Pain (Dpnp) ( 1 ) • Chronic Musculoskeletal Pain ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Duloxetine Hydrochloride DULOXETINE HYDROCHLORIDE ZINC1536779

Comments